There's currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

The tiny bits of plastic pollution that make their way from the environment into our bodies accumulate at much higher ...

A new study showed that people who took longer to enter this dream phase of sleep had higher levels of amyloid beta and tau, ...

According to new research, a certain type of exercise may be the key to slashing your risk of developing Alzheimer's ...

Trusted resource of information on Alzheimer's Disease that includes articles, news, videos, animations, quizzes, calculators ...

Cognitively normal human brain samples collected at autopsy in early 2024 contained more tiny shards of plastic than samples ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Novo Nordisk CEO Lars Fruergaard Jørgensen weighs in the company's latest obesity drug offering, including its new oral weight loss candidate.